DOUGLAS K BRATTON Insider Trading $DNLI Denali Therapeutics Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DOUGLAS K BRATTON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DOUGLAS K BRATTON. DOUGLAS K BRATTON is Director in MIDWEST HOLDING INC. ($NONE.) and in Aquestive Therapeutics, Inc. ($AQST) and Director in Aquestive Therapeutics, Inc. ($AQST) and 10% Owner in Juno Therapeutics, Inc. ($JUNO) and 10% Owner in Denali Therapeutics Inc. ($DNLI).
DOUGLAS K BRATTON in Denali Therapeutics Inc.
Trading Symbol: DNLIIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DOUGLAS K BRATTON: 10% Owner
Holdings: 9,984,836 shares
Latest Transaction: Feb 17 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DOUGLAS K BRATTON in Denali Therapeutics Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AQST, DNLI, JUNO, MDWT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2021 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 65.00 | 2,216,798 | 144,091,870 | 9,984,836 | 12.2 M to 10 M (-18.17 %) |
Dec 23 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | J | 0.00 | 383,411 | 0 | 0 | 383.4 K to 0 (-100.00 %) |
Dec 15 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 81.13 | 876 | 71,068 | 383,411 | 384.3 K to 383.4 K (-0.23 %) |
Dec 15 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 80.35 | 16,949 | 1,361,774 | 384,287 | 401.2 K to 384.3 K (-4.22 %) |
Dec 15 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 80.05 | 46,799 | 3,746,442 | 401,236 | 448 K to 401.2 K (-10.45 %) |
Dec 15 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 81.13 | 876 | 71,068 | 383,411 | 384.3 K to 383.4 K (-0.23 %) |
Dec 15 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 80.35 | 16,949 | 1,361,774 | 384,287 | 401.2 K to 384.3 K (-4.22 %) |
Dec 15 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 80.05 | 46,799 | 3,746,442 | 401,236 | 448 K to 401.2 K (-10.45 %) |
Aug 14 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 31.65 | 1,443,247 | 45,678,768 | 12,201,634 | 13.6 M to 12.2 M (-10.58 %) |
Aug 14 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 31.65 | 1,443,247 | 45,678,768 | 12,201,634 | 13.6 M to 12.2 M (-10.58 %) |
Jun 30 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 24.34 | 200 | 4,868 | 448,035 | 448.2 K to 448 K (-0.04 %) |
Jun 30 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 24.01 | 45,145 | 1,083,733 | 448,235 | 493.4 K to 448.2 K (-9.15 %) |
Jun 30 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 24.50 | 20,771 | 508,975 | 493,380 | 514.2 K to 493.4 K (-4.04 %) |
Jun 30 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 23.84 | 61,807 | 1,473,399 | 514,151 | 576 K to 514.2 K (-10.73 %) |
Jun 30 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 24.67 | 13,604 | 335,637 | 575,958 | 589.6 K to 576 K (-2.31 %) |
Jun 30 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 23.84 | 108,473 | 2,586,441 | 589,562 | 698 K to 589.6 K (-15.54 %) |
Jun 23 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 26.19 | 3,247 | 85,028 | 698,035 | 701.3 K to 698 K (-0.46 %) |
Jun 23 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 25.69 | 16,777 | 430,941 | 701,282 | 718.1 K to 701.3 K (-2.34 %) |
Jun 23 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 25.12 | 24,683 | 619,960 | 718,059 | 742.7 K to 718.1 K (-3.32 %) |
Jun 23 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 24.66 | 65,373 | 1,611,941 | 742,742 | 808.1 K to 742.7 K (-8.09 %) |
Jun 23 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 25.00 | 62,439 | 1,560,850 | 808,115 | 870.6 K to 808.1 K (-7.17 %) |
Jun 23 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 24.20 | 82,481 | 1,995,653 | 870,554 | 953 K to 870.6 K (-8.65 %) |
Jun 09 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 25.75 | 1,922,855 | 49,513,516 | 13,644,881 | 15.6 M to 13.6 M (-12.35 %) |
Apr 09 2019 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | J | 0.00 | 158,764 | 0 | 953,035 | 1.1 M to 953 K (-14.28 %) |
Apr 09 2019 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | J | 0.00 | 158,764 | 0 | 953,035 | 1.1 M to 953 K (-14.28 %) |
Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 240,000 | 0 | 0 | |
Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 128,200 | 0 | 0 | |
Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 743,599 | 0 | 0 | |
Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 1,875,000 | 0 | 0 | |
Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 2,500,000 | 0 | 0 | |
Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 14,499,999 | 0 | 0 | |
Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Buy | P | 18.00 | 275,000 | 4,950,000 | 19,462,499 | 19.2 M to 19.5 M (+1.43 %) |
Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 240,000 | 0 | 1,111,799 | 871.8 K to 1.1 M (+27.53 %) |
Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 128,200 | 0 | 871,799 | 743.6 K to 871.8 K (+17.24 %) |
Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 743,599 | 0 | 743,599 | 0 to 743.6 K |
Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 1,875,000 | 0 | 19,187,499 | 17.3 M to 19.2 M (+10.83 %) |
Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 2,500,000 | 0 | 17,312,499 | 14.8 M to 17.3 M (+16.88 %) |
Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 14,499,999 | 0 | 14,812,499 | 312.5 K to 14.8 M (+4,640.00 %) |
Page: 1